A Phase 1/2 Pharmacokinetic Guided Dose-Escalation and Dose-Confirmation Study of ASTX727, A Combination of the Oral Cytidine Deaminase Inhibitor (CDAi) E7727 with Oral Decitabine in Subjects with Myelodysplastic Syndromes (MDS)
NOT ENROLLING
Trial ID:
NCT02103478 Protocol # :
14-195
Phase
I/II
Disease Sites
Lymphoid Leukemia
Myeloid and Monocytic Leukemia
Leukemia, other
Principal Investigator
Steensma, David, Peter
Site Investigator
Amrein, Philip, C.
Attar, Eyal, C.
Site Research Nurses
Toomey-Mathews, Ellen
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #14-195
14-195